HER2 ICD vaccine trial findings featured on KIRO7 news
Nov 21, 2022
1 min read
CVI's Executive Director Dr. Kiran Dhillon spoke with KIRO7 news anchors Monique Ming Laven and Gary Horcher about our recent publication in JAMA Oncology describing our Phase I clinical trial with the HER2 ICD DNA vaccine. It was a great opportunity for us to share about cancer vaccine research happening at UW Medicine Cancer Vaccine Institute.
